I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Predicting survival of NSCLC patients treated with immune c..:
Michael R. Sayer
;
Isa Mambetsariev
;
Kun-Han Lu
...
https://www.frontiersin.org/articles/10.3389/fonc.2023.1064169/full. , 2023
Link:
https://doi.org/10.3389/fonc.2023.1064169
RT Journal T1
Predicting survival of NSCLC patients treated with immune checkpoint inhibitors: Impact and timing of immune-related adverse events and prior tyrosine kinase inhibitor therapy
UL https://suche.suub.uni-bremen.de/peid=base-ftdoajarticles:oai:doaj.org_article:913684591c4f46bdad1761462ca8ca13&Exemplar=1&LAN=DE A1 Michael R. Sayer A1 Isa Mambetsariev A1 Kun-Han Lu A1 Chi Wah Wong A1 Ashley Duche A1 Richard Beuttler A1 Jeremy Fricke A1 Rebecca Pharoan A1 Leonidas Arvanitis A1 Zahra Eftekhari A1 Arya Amini A1 Marianna Koczywas A1 Erminia Massarelli A1 Moom Rahman Roosan A1 Ravi Salgia PB Frontiers Media S.A. YR 2023 K1 non-small cell lung cancer K1 immunotherapy K1 immune-related adverse events K1 tyrosine kinase inhibitors (TKI) K1 machine learning K1 survival analysis K1 Neoplasms. Tumors. Oncology. Including cancer and carcinogens K1 RC254-282 JF https://www.frontiersin.org/articles/10.3389/fonc.2023.1064169/full LK http://dx.doi.org/https://doi.org/10.3389/fonc.2023.1064169 DO https://doi.org/10.3389/fonc.2023.1064169 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)